Business Description
Basilea Pharmaceutica Ltd
ISIN : CH0011432447
Description
Financial Strength
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.47 | |||||
Equity-to-Asset | -0.06 | |||||
Debt-to-Equity | -12.86 | |||||
Debt-to-EBITDA | 5.53 | |||||
Interest Coverage | 1.96 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | -4.27 | |||||
Beneish M-Score | -3.03 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 1.5 | |||||
3-Year Book Growth Rate | 55.4 | |||||
Future 3-5Y EPS without NRI Growth Rate | 74.07 | |||||
Future 3-5Y Total Revenue Growth Rate | 13.85 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.2 | |||||
Quick Ratio | 2.64 | |||||
Cash Ratio | 1.26 | |||||
Days Inventory | 346.43 | |||||
Days Sales Outstanding | 77.73 | |||||
Days Payable | 45.32 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -3.4 | |||||
Shareholder Yield % | 10.65 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 83 | |||||
Operating Margin % | 13.9 | |||||
Net Margin % | 6.63 | |||||
FCF Margin % | 5.96 | |||||
ROE % | Neg. Equity | |||||
ROA % | 5.02 | |||||
ROIC % | 17.22 | |||||
ROC (Joel Greenblatt) % | 36.42 | |||||
ROCE % | 14.96 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 71.19 | |||||
Forward PE Ratio | 19.26 | |||||
PE Ratio without NRI | 71.19 | |||||
Price-to-Owner-Earnings | 102.16 | |||||
PS Ratio | 3.67 | |||||
Price-to-Free-Cash-Flow | 51.55 | |||||
Price-to-Operating-Cash-Flow | 47.16 | |||||
EV-to-EBIT | 28.16 | |||||
EV-to-EBITDA | 26.25 | |||||
EV-to-Revenue | 3.87 | |||||
EV-to-FCF | 46.18 | |||||
Price-to-Median-PS-Value | 0.73 | |||||
Earnings Yield (Greenblatt) % | 3.55 | |||||
FCF Yield % | 2.44 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Basilea Pharmaceutica Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 156.417 | ||
EPS (TTM) (€) | -1.898 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 0 | ||
14-Day ATR (€) | 0 | ||
20-Day SMA (€) | 32.28 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (€) | 32.28 - 32.28 | ||
Shares Outstanding (Mil) | 12 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Basilea Pharmaceutica Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Basilea Pharmaceutica Ltd Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Basilea Pharmaceutica Ltd Frequently Asked Questions
What is Basilea Pharmaceutica Ltd(FRA:PK5)'s stock price today?
When is next earnings date of Basilea Pharmaceutica Ltd(FRA:PK5)?
Does Basilea Pharmaceutica Ltd(FRA:PK5) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |